Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction.
Manoharan, Ganesh
Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction. [electronic resource] - Clinical cardiology Jul 2004 - 381-6 p. digital
Publication Type: Journal Article; Review
0160-9289
10.1002/clc.4960270703 doi
Angioplasty, Balloon, Coronary
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Coronary Stenosis--therapy
Drug Therapy, Combination
Fibrinolytic Agents--therapeutic use
Humans
Myocardial Infarction--therapy
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Thrombolytic Therapy
Vascular Patency--drug effects
Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction. [electronic resource] - Clinical cardiology Jul 2004 - 381-6 p. digital
Publication Type: Journal Article; Review
0160-9289
10.1002/clc.4960270703 doi
Angioplasty, Balloon, Coronary
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Coronary Stenosis--therapy
Drug Therapy, Combination
Fibrinolytic Agents--therapeutic use
Humans
Myocardial Infarction--therapy
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Thrombolytic Therapy
Vascular Patency--drug effects